Artemisinin-Based Combination Antimalarial (ACT)
Artemether with Lumefantrine
Brand names: Riamet, Coartem
Adult dose
Dose: 4 tablets per dose (80 mg/480 mg total), given at 0, 8, 24, 36, 48, and 60 hours (6 doses total over 3 days; adult >35 kg)
Route: Oral
Frequency: 6 doses as above — MUST be taken with fat-containing food/drink
Clinical pearls
- WHO-recommended and UKHSA/PHE first-line ACT for uncomplicated Plasmodium falciparum malaria (including imported cases)
- MUST be taken with food containing fat (biscuits, milk, porridge) — significantly increases lumefantrine bioavailability
- PHE/UKHSA Guidelines for Malaria Prevention in Travellers from UK (2022): artemether-lumefantrine is first choice for treatment of uncomplicated P. falciparum
- For severe malaria: IV artesunate is preferred (not artemether-lumefantrine)
- Complete all 6 doses even if feeling better to prevent recrudescence
- Monitor ECG if QT prolongation history or concomitant QT drugs
Contraindications
- QTc interval prolongation
- Concomitant QT-prolonging drugs
- Severe hepatic impairment
- Hypersensitivity
Side effects
- Headache
- Dizziness
- Nausea, vomiting
- Arthralgia, myalgia
- QT prolongation
- Neutropenia (common — usually transient)
Interactions
- QT-prolonging drugs — additive QT prolongation; avoid
- CYP3A4 inducers (rifampicin, carbamazepine) — reduce lumefantrine levels; avoid
- Antiretrovirals (especially efavirenz, lopinavir) — complex interactions; check BNF/ASHP
- Antimalarial drugs containing mefloquine — avoid within 12 hours (seizure risk)
Monitoring
- Parasitaemia (blood film at baseline, 72 hours, 28 days)
- Temperature response (fever should resolve within 48–72 hours)
- Full blood count (neutropenia, anaemia)
- QTc if risk factors
- Renal and hepatic function in severe illness
Reference: BNF; PHE/UKHSA Guidelines for Malaria Prevention and Treatment (2022); WHO Guidelines for Treatment of Malaria (3rd edition, 2015 updated); NICE CKS Malaria (2023); https://bnf.nice.org.uk/drugs/artemether-with-lumefantrine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- HE-MACS (History and ECG-Based Manchester ACS Risk Score) · ACS Risk Stratification
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Number Needed to Treat (NNT) / Number Needed to Harm (NNH) · Evidence-Based Medicine
- HIV Opportunistic Infection Risk (CD4-Based) · HIV / Immunodeficiency
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- Estimated Bladder Capacity (Age-based) · Urodynamics
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023